RxSight, Inc. (RXST) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
RXST currently has 41.3M outstanding shares. with moderate dilution risk from 11.6M authorized shares representing 28.2% potential dilution. The company has minimally diluted shareholders by 9.64% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 41.3M shares outstanding |
41M | 12M |
| Nov 05, 2025 |
10-Q filing | 41.0M shares outstanding |
41M | 12M |
| Aug 07, 2025 |
10-Q filing | 40.7M shares outstanding |
41M | 12M |
| May 07, 2025 |
10-Q filing | 40.5M shares outstanding |
41M | 12M |
| Feb 25, 2025 |
10-K filing | 38.9M shares outstanding |
39M | 12M |
| Nov 07, 2024 |
10-Q filing | 39.8M shares outstanding |
40M | 12M |
| Aug 05, 2024 |
10-Q filing | 38.5M shares outstanding |
38M | 12M |
| May 06, 2024 |
10-Q filing | 36.8M shares outstanding |
37M | 12M |
| Feb 28, 2024 |
10-K filing | 34.5M shares outstanding |
34M | 12M |
| Nov 09, 2023 |
10-Q filing | 35.7M shares outstanding |
36M | 12M |
| Aug 07, 2023 |
10-Q filing | 34.5M shares outstanding |
34M | 12M |
| Jul 05, 2023 |
8-K filing: RxSight, Inc. sold 834,748 common shares through its ATM facility for approximately $19.4 million in net proceeds and entered into a new $20.0 million loan and security agreement with Oxford Finance, LLC. ($19.4M proceeds) |
32M | 12M |
| May 09, 2023 |
10-Q filing | 31.6M shares outstanding |
32M | 12M |
| Mar 06, 2023 |
10-K filing | 33.8M shares outstanding |
34M | 12M |
| Nov 07, 2022 |
10-Q filing | 27.7M shares outstanding |
28M | 12M |
| Aug 08, 2022 |
10-Q filing | 27.6M shares outstanding |
28M | 12M |
| Aug 08, 2022 |
S-3 filing: The company is filing an S-3 to offer common stock, preferred stock, and debt securities up to an aggregate amount of $200,000,000 from time to time. |
28M | 12M |
| May 05, 2022 |
10-Q filing | 27.5M shares outstanding |
28M | 8.5M |
| Mar 08, 2022 |
10-K filing | 27.4M shares outstanding |
27M | 8.5M |
| Nov 10, 2021 |
10-Q filing | 27.4M shares outstanding |
27M | 8.5M |
| Sep 09, 2021 |
10-Q filing | 27.3M shares outstanding |
27M | 8.5M |
| Jul 28, 2021 |
S-1/A filing: This is an S-1/A filing for the initial public offering of common stock by RxSight, Inc. with an expected price between $16.00 and $18.00 per share. The underwriters have an option to purchase up to 1,102,500 additional shares. The company intends to list its common stock on the Nasdaq Global Market under the symbol RXST. |
19M | 8.5M |
| Jul 26, 2021 |
S-1/A filing: This is an S-1/A filing for the initial public offering of common stock by RxSight, Inc. with an expected price between $16.00 and $18.00 per share. The company intends to list its common stock on the Nasdaq Global Market under the symbol RXST. |
19M | 7.6M |
| Jul 09, 2021 |
S-1 filing: This is an S-1 filing for the initial public offering of RxSight, Inc.'s common stock. The filing includes details about the offering price, potential use of proceeds, and shares outstanding. |
200M | 0 |